GL1X · GenesisL1 explorer

MolNFT v1 · #66454 · protein

PHD2:FE:UN9:PARTIAL HIF1-alpha substrate complex

3HQU · Egl nine homolog 1: “PHD2:FE:UN9:PARTIAL HIF1-alpha substrate complex”. X-ray diffraction, 2 ligands (UN9, FE2), 1 pocket (best druggability 0.64). MolNFT v1 #66454 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3HQU
Type
protein
Length
222 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Egl nine homolog 1; Hypoxia-inducible factor 1 alpha
EC
1.14.11.-
UniProt
Q9GZT9, Q16665
Ligands
UN9, FE2
Pockets
1 · best druggability 0.64

Structure

x-ray diffraction · 2 distinct chains · 27% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEgl nine homolog 1 (EC 1.14.11.-)protein21528% helix, 32% strandQ9GZT9
SHypoxia-inducible factor 1 alphaprotein70% helix, 14% strandQ16665

Ligands and binding sites

  • UN9 · N-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine · ligand · chains A
  • FE2 · Fe (II) ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11390.640.8625FE2, UN9

Interfaces

1 interface between chains.

  • A–S · 576 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 3HQU · PHD2:Fe:UN9:partial HIF1-alpha substrate complex · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9GZT9 · AlphaFold monomer V2.0 prediction for egl nine homolog 1 (Q9GZT9) · a predicted model of the same protein · chain A against A, TM-score 0.93
  • Q16665 · AlphaFold monomer V2.0 prediction for hypoxia-inducible factor 1-alpha (Q16665) · a predicted model of the same protein · chain S against A, TM-score 0.65

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.